Bioxyne Raises A$3 million in Capital Raise
Filed with ASX · · 3 pages · English
Earlier from Bioxyne
- Trading Halt
- Pause in Trading
- BXN H1 FY25 Results Presentation
- Quarterly Activities Report December 2024 Revised
- Revenue Guidance
Later from Bioxyne
- BXN Signs Exclusive $7m Manufacturing and Supply Agreement
- FY25 Revenue Guidance Upgrade
- Certificate GMP Compliance EU, UK, Singapore & Canada
- Enters German Market Euro3.2m Manufacturing & Supply Agmt
- Investor Presentation Update
Follow Bioxyne into a list and get an email when it puts out news.
Follow Bioxyne